MAKO Surgical has had a rough go of it lately after revising guidance down twice in as many quarters. The recent disappointing sales of its RIO system has come to roost in the management suite as VP of sales Stephen Nunes resigned and CEO Maurice Ferre will take over on an interim basis. Watch and find out what it all means for investors and whether the management shakeup will help rebound a stock 70% off its 52-week high.
Instead of putting all of your eggs in the biotech basket, why not diversify into some solid dividend-paying companies? Fortunately, the Dow is loaded with companies with strong dividend payouts and highly sustainable business models built for the long haul. The 3 Dow Stocks Dividend Investors Need all have an X factor that makes them stand out from their illustrious Dow peers. Download our special free report on these three companies by clicking here.
At the time thisarticle was published David Williamsonowns shares of MAKO Surgical, but he holds no other position in any company mentioned. Check out his holdings and a short bio.The Motley Fool owns shares of Intuitive Surgical and MAKO Surgical.Motley Fool newsletter serviceshave recommended buying shares of Intuitive Surgical and MAKO Surgical. We Fools don't all hold the same opinions, but we all believe thatconsidering a diverse range of insightsmakes us better investors. Try any of our Foolish newsletter servicesfree for 30 days. The Motley Fool has adisclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.